Adhesive capsulitis of shoulder

Jump to navigation Jump to search

Template:Adhesive Capsulitis of Shoulder Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Marufa Marium, M.B.B.S[2]

WikiDoc Resources for Adhesive capsulitis of shoulder

Articles

Most recent articles on Adhesive capsulitis of shoulder

Most cited articles on Adhesive capsulitis of shoulder

Review articles on Adhesive capsulitis of shoulder

Articles on Adhesive capsulitis of shoulder in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Adhesive capsulitis of shoulder

Images of Adhesive capsulitis of shoulder

Photos of Adhesive capsulitis of shoulder

Podcasts & MP3s on Adhesive capsulitis of shoulder

Videos on Adhesive capsulitis of shoulder

Evidence Based Medicine

Cochrane Collaboration on Adhesive capsulitis of shoulder

Bandolier on Adhesive capsulitis of shoulder

TRIP on Adhesive capsulitis of shoulder

Clinical Trials

Ongoing Trials on Adhesive capsulitis of shoulder at Clinical Trials.gov

Trial results on Adhesive capsulitis of shoulder

Clinical Trials on Adhesive capsulitis of shoulder at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Adhesive capsulitis of shoulder

NICE Guidance on Adhesive capsulitis of shoulder

NHS PRODIGY Guidance

FDA on Adhesive capsulitis of shoulder

CDC on Adhesive capsulitis of shoulder

Books

Books on Adhesive capsulitis of shoulder

News

Adhesive capsulitis of shoulder in the news

Be alerted to news on Adhesive capsulitis of shoulder

News trends on Adhesive capsulitis of shoulder

Commentary

Blogs on Adhesive capsulitis of shoulder

Definitions

Definitions of Adhesive capsulitis of shoulder

Patient Resources / Community

Patient resources on Adhesive capsulitis of shoulder

Discussion groups on Adhesive capsulitis of shoulder

Patient Handouts on Adhesive capsulitis of shoulder

Directions to Hospitals Treating Adhesive capsulitis of shoulder

Risk calculators and risk factors for Adhesive capsulitis of shoulder

Healthcare Provider Resources

Symptoms of Adhesive capsulitis of shoulder

Causes & Risk Factors for Adhesive capsulitis of shoulder

Diagnostic studies for Adhesive capsulitis of shoulder

Treatment of Adhesive capsulitis of shoulder

Continuing Medical Education (CME)

CME Programs on Adhesive capsulitis of shoulder

International

Adhesive capsulitis of shoulder en Espanol

Adhesive capsulitis of shoulder en Francais

Business

Adhesive capsulitis of shoulder in the Marketplace

Patents on Adhesive capsulitis of shoulder

Experimental / Informatics

List of terms related to Adhesive capsulitis of shoulder

For patient information, click here

Synonyms and keywords: Frozen shoulder syndrome; Adhesive capsulitis; Duplay Bursitis, Scapulohumeral periarthritis; Arthofibrosis; Shoulder pain; Shoulder stiffness; Shoulder Capsulitis.

Overview

Adhesive capsulitis is an inflammatory insult to glenohumeral joint limiting active and passive range of motion due to pain and stiffness of shoulder joint. The active and passive range of motion is debilitated due to inflammation and fibrosis of adhesive bursa due to primary and secondary causes.

Historical Perspective

  • Adhesive capsulitis was first discovered by Simon Emmanuel Duplay, a French surgeon, in 1872 who introduced the term 'scapulohumeral periarthritis' to identify painful shoulder with normal preservation of imaging findings. In 1934 Earnest Codman termed it as Frozen Shoulder' as there was loss of range of motion at shoulder joint. Later in 1945, due to the involvement of inflammation of capsule leading to fibrosis of bursa was elaborated by Julius Neviaser, he named it 'Adhesive capsulitis'.[1][2]

Classification

  • Adhesive Capsulitis may be classified according to etiology into two groups:
  • Primary or Idiopathic:
    • Adhesive capsulitis can occur spontaneously without concurrent shoulder joint abnormality or inciting factors
  • Secondary:
    • Adhesive capsulitis can present due to preexistent shoulder joint dysfunction for instances glenohumeral joint dislocation with fracture of periarticular region, joint trauma, arthroscopic surgery to shoulder joint, arthroplasty or rotator cuff injury repair. [3][4]


Pathophysiology

  • The pathogenesis of adhesive capsulitis is characterized by inflammation and fibrosis which is elaborated several pathways mentioned below.
    • In the beginning it was thought myofibroblasts are playing role in fibrotic pathway. low levels of metalloproteinases (MMPs) like MMP-14, MMP-1, MMP-2 and increased expression of tissue inhibitor of metalloproteinases (TIMPs) for instances TIMP-1, TIMP-2 resulting in ECM imbalances and fibrosis.[5]
    • Inflammatory process involving IL-1 alpha, IL-1 beta, TNF- alpha, COX-1 and COX-2 leading to accumulation of macrophages, T and B cells, mast cells are recently thought to have role adhesive capsulitis. [6]
    • Molecules like ICAM-1, SNP(single- peptide polymorphism of Interleukin-6), metalloproteinases-3, IGF-2, Beta catenin are involved in genetic association with adhesive capsulitis.[1] [7] [8]
    • In recent studies the intolerable pain of adhesive capsulitis is explained by the involvement of nerve invasion by nerve growth factor receptor p75. VEGF, MAPK(mitogen-activated protein kinases)/ENK pathway and MAPK/JNK, Beta-1 integrin(CD19), CD34,PGP9.5(Protein gene product 9.5), GAP43(growth associated protein 43), NF-kB, TGF- beta are elevated in pathogenesis in Adhesive capsulitis.[9][10] [11][6]
  • On gross pathology, inflammation, congestion, fibrosis of capsule are characteristic findings of adhesive capsulitis.
  • On microscopic histopathological analysis, cellular infiltration with accumulation of macrophages, T and B cells, mast cells are characteristic findings of adhesive capsulitis.

Causes

Disease name] may be caused by [cause1], [cause2], or [cause3].

OR

Common causes of [disease] include [cause1], [cause2], and [cause3].

OR

The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].

OR

The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click here.

Differentiating [disease name] from other Diseases

For further information about the differential diagnosis, click here.

Epidemiology and Demographics

  • The prevalence of [disease name] is approximately [number or range] per 100,000 individuals worldwide.
  • In [year], the incidence of [disease name] was estimated to be [number or range] cases per 100,000 individuals in [location].

Age

  • Patients of all age groups may develop [disease name].
  • [Disease name] is more commonly observed among patients aged [age range] years old.
  • [Disease name] is more commonly observed among [elderly patients/young patients/children].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected with [disease name] than [gender 2].
  • The [gender 1] to [Gender 2] ratio is approximately [number > 1] to 1.

Race

  • There is no racial predilection for [disease name].
  • [Disease name] usually affects individuals of the [race 1] race.
  • [Race 2] individuals are less likely to develop [disease name].

Risk Factors

  • Common risk factors in the development of [disease name] are [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Natural History, Complications and Prognosis

  • The majority of patients with [disease name] remain asymptomatic for [duration/years].
  • Early clinical features include [manifestation 1], [manifestation 2], and [manifestation 3].
  • If left untreated, [#%] of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
  • Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
  • Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis

Diagnostic Criteria

  • The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:
  • [criterion 1]
  • [criterion 2]
  • [criterion 3]
  • [criterion 4]

Symptoms

  • [Disease name] is usually asymptomatic.
  • Symptoms of [disease name] may include the following:
  • [symptom 1]
  • [symptom 2]
  • [symptom 3]
  • [symptom 4]
  • [symptom 5]
  • [symptom 6]

Physical Examination

  • Patients with [disease name] usually appear [general appearance].
  • Physical examination may be remarkable for:
  • [finding 1]
  • [finding 2]
  • [finding 3]
  • [finding 4]
  • [finding 5]
  • [finding 6]

Laboratory Findings

  • There are no specific laboratory findings associated with [disease name].
  • A [positive/negative] [test name] is diagnostic of [disease name].
  • An [elevated/reduced] concentration of [serum/blood/urinary/CSF/other] [lab test] is diagnostic of [disease name].
  • Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Electrocardiogram

There are no ECG findings associated with [disease name].

OR

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

X-ray

There are no x-ray findings associated with [disease name].

OR

An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Echocardiography or Ultrasound

There are no echocardiography/ultrasound findings associated with [disease name].

OR

Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

CT scan

There are no CT scan findings associated with [disease name].

OR

[Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

Other Imaging Findings

There are no other imaging findings associated with [disease name].

OR

[Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Other Diagnostic Studies

  • [Disease name] may also be diagnosed using [diagnostic study name].
  • Findings on [diagnostic study name] include [finding 1], [finding 2], and [finding 3].

Treatment

Medical Therapy

  • There is no treatment for [disease name]; the mainstay of therapy is supportive care.
  • The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
  • [Medical therapy 1] acts by [mechanism of action 1].
  • Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery

  • Surgery is the mainstay of therapy for [disease name].
  • [Surgical procedure] in conjunction with [chemotherapy/radiation] is the most common approach to the treatment of [disease name].
  • [Surgical procedure] can only be performed for patients with [disease stage] [disease name].

Prevention

  • There are no primary preventive measures available for [disease name].
  • Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
  • Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].


Differentiating Adhesive Capsulitis of Shoulder from other Diseases

Epidemiology and Demographics

It has an incidence of 2,400 out of every 100,000 patients per year.[12]

Risk Factors

Most of the time there is no cause for frozen shoulder. Risk factors include:

Natural History, Complications and Prognosis

Complications

  • Stiffness and pain continue even with therapy.
  • The arm can break if the shoulder is moved forcefully during surgery.

Prognosis

Treatment with physical therapy and NSAIDs will usually restore motion and function of the shoulder within a year. Even untreated, the shoulder can get better by itself in 24 months.

After surgery restores motion, you must continue physical therapy for several weeks or months to prevent the frozen shoulder from returning. Treatment may fail if you cannot keep up with physical therapy.

Diagnosis

History and Symptoms

Movement of the shoulder is severely restricted. The condition is sometimes caused by injury that leads to lack of use due to pain but also often arises spontaneously with no obvious preceding trigger factor. These seemingly spontaneous cases are usually referred to as Idiopathic Frozen Shoulder. Rheumatic disease progression and recent shoulder surgery can also cause a pattern of pain and limititation similar to frozen shoulder. Intermittent periods of use may cause inflammation.

Abnormal bands of tissue (adhesions) grow between the joint surfaces, restricting motion. There is also a lack of synovial fluid, which normally helps the shoulder joint move by lubricating the gap between the humerus (upper arm bone) and the socket in the scapula (shoulder blade). It is this restricted space between the capsule and ball of the humerus that distinguishes adhesive capsulitis from a less complicated, painful, stiff shoulder. People with diabetes, stroke, lung disease, rheumatoid arthritis, and heart disease, or who have been in an accident, are at a higher risk for frozen shoulder. Adhesive capsulitis has been indicated as a possible adverse effect of some forms of highly active antiretroviral therapy (HAART). The condition rarely appears in people under 40 years old and (at least in its idiopathic form) is much more common in women than in men (70% of patients are women aged 40-60). Frozen shoulder in diabetic patients is generally thought to be a more troublesome condition than in the non-diabetic population. [13] If a diabetic patient develops frozen shoulder then the time to full recovery is often prolonged from the usual 12 month period.

Physical Examination

With a frozen shoulder, one sign is that the joint becomes so tight and stiff that it is nearly impossible to carry out simple movements, such as raising the arm. People complain that the stiffness and pain worsen at night. Pain due to frozen shoulder is usually dull or aching. It can be worsened with attempted motion. A doctor, or therapist (occupational, massage or physical), may suspect the patient has a frozen shoulder if a physical examination reveals limited shoulder movement. Frozen shoulder can also be diagnosed if limits to the active range of motion (range of motion from active use of muscles) are the same or almost the same as the limits to the passive range of motion (range of motion from a person manipulating the arm and shoulder).

Physicians have described the normal course of a frozen shoulder as having three stages:[14]

  • Stage one: In the "freezing" or painful stage, which may last from six weeks to nine months, the patient has a slow onset of pain. As the pain worsens, the shoulder loses motion.
  • Stage two: The "frozen" or adhesive stage is marked by a slow improvement in pain, but the stiffness remains. This stage generally lasts four months to nine months.
  • Stage three: The "thawing" or recovery, during which shoulder motion slowly returns toward normal. This generally lasts five months to 26 months.

MRI

An arthrogram or an MRI scan may confirm the diagnosis - although in practice this is rarely required. Most orthopedic specialists make the diagnosis of frozen shoulder by recognizing the typical pattern of signs and symptoms.

Shown below are MRI images from a patient with adhesive capsulitis.

Treatment

Medical Therapy

Management of this disorder focuses on restoring joint movement and reducing shoulder pain. Usually, it begins with nonsteroidal anti-inflammatory drugs (NSAIDs) and the application of heat, followed by gentle stretching exercises. These stretching exercises, which may be performed in the home with the help of a physical, massage or occupational therapist, are the treatment of choice. In some cases, transcutaneous electrical nerve stimulation (TENS) with a small battery-operated unit may be used to reduce pain by blocking nerve impulses. The next step often involves one or a series of steroid injections (up to six).

If these measures are unsuccessful, the doctor may recommend manipulation of the shoulder under general anesthesia to break up the adhesions. Surgery to cut the adhesions is only necessary in some cases.

Alternative medicine treatments include:

Primary Prevention

To prevent the problem, a common recommendation is to keep the shoulder joint fully moving to prevent a frozen shoulder. Often a shoulder will hurt when it begins to freeze. Because pain discourages movement, further development of adhesions that restrict movement will occur unless the joint continues to move full range in all directions (adduction, abduction, flexion, rotation, and extension). Therapy will help one continue movement to discourage freezing and warm it. A medical doctor referral is needed before occupational or physical therapy can begin under law in most US states. Medical referral is not required for physical or occupational therapy in most Canadian provinces.

Related Chapters

References

  1. 1.0 1.1 Le HV, Lee SJ, Nazarian A, Rodriguez EK (April 2017). "Adhesive capsulitis of the shoulder: review of pathophysiology and current clinical treatments". Shoulder Elbow. 9 (2): 75–84. doi:10.1177/1758573216676786. PMC 5384535. PMID 28405218.
  2. Dias R, Cutts S, Massoud S (December 2005). "Frozen shoulder". BMJ. 331 (7530): 1453–6. doi:10.1136/bmj.331.7530.1453. PMC 1315655. PMID 16356983.
  3. Bailie DS, Llinas PJ, Ellenbecker TS (January 2008). "Cementless humeral resurfacing arthroplasty in active patients less than fifty-five years of age". J Bone Joint Surg Am. 90 (1): 110–7. doi:10.2106/JBJS.F.01552. PMID 18171964.
  4. McAlister I, Sems SA (April 2016). "Arthrofibrosis After Periarticular Fracture Fixation". Orthop Clin North Am. 47 (2): 345–55. doi:10.1016/j.ocl.2015.09.003. PMID 26772943.
  5. Lubis AM, Lubis VK (July 2013). "Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise". J Orthop Sci. 18 (4): 519–27. doi:10.1007/s00776-013-0387-0. PMID 23604641.
  6. 6.0 6.1 Hand GC, Athanasou NA, Matthews T, Carr AJ (July 2007). "The pathology of frozen shoulder". J Bone Joint Surg Br. 89 (7): 928–32. doi:10.1302/0301-620X.89B7.19097. PMID 17673588.
  7. Kim YS, Kim JM, Lee YG, Hong OK, Kwon HS, Ji JH (February 2013). "Intercellular adhesion molecule-1 (ICAM-1, CD54) is increased in adhesive capsulitis". J Bone Joint Surg Am. 95 (4): e181–8. doi:10.2106/JBJS.K.00525. PMID 23426775.
  8. Raykha CN, Crawford JD, Burry AF, Drosdowech DS, Faber KJ, Gan BS, O'Gorman DB (August 2014). "IGF2 expression and β-catenin levels are increased in Frozen Shoulder Syndrome". Clin Invest Med. 37 (4): E262–7. doi:10.25011/cim.v37i4.21733. PMID 25090267.
  9. Kanbe K, Inoue K, Inoue Y, Chen Q (January 2009). "Inducement of mitogen-activated protein kinases in frozen shoulders". J Orthop Sci. 14 (1): 56–61. doi:10.1007/s00776-008-1295-6. PMC 2893737. PMID 19214689.
  10. Xu Y, Bonar F, Murrell GA (October 2012). "Enhanced expression of neuronal proteins in idiopathic frozen shoulder". J Shoulder Elbow Surg. 21 (10): 1391–7. doi:10.1016/j.jse.2011.08.046. PMID 22005128.
  11. Watson RS, Gouze E, Levings PP, Bush ML, Kay JD, Jorgensen MS, Dacanay EA, Reith JW, Wright TW, Ghivizzani SC (November 2010). "Gene delivery of TGF-β1 induces arthrofibrosis and chondrometaplasia of synovium in vivo". Lab Invest. 90 (11): 1615–27. doi:10.1038/labinvest.2010.145. PMC 3724510. PMID 20697373.
  12. Walters J, Howes F, Buchbinder R (2007). "Oral corticosteroids--their place in the management of adhesive capsulitis". Aust Fam Physician. 36 (11): 927–9. PMID 18043780.
  13. "Questions and Answers about Shoulder Problems". Retrieved 2008-01-28.
  14. "Your Orthopaedic Connection: Frozen Shoulder". Retrieved 2008-01-28.

External Links

Template:Diseases of the musculoskeletal system and connective tissue hr:Ukrućeno rame nl:Frozen shoulder sv:Adhesiv kapsulit


Template:WikiDoc Sources